'New Frontiers in Point-of-Care/POC Clinical Chemistry and Immunodiagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape' is Venture Planning Group’s new report, which provides comprehensive analysis of the POC clinical chemistry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
Review of the POC clinical chemistry and immunodiagnostic market segments, including their dynamics, trends, structure, size, growth and major suppliers.
Five-year test volume and reagent sales forecasts clinical chemistry procedures by market segment:
Physician Offices/Group Practices
Ambulatory Care Centers
Sales and Market Share Analysis
Sales and market shares of major reagent and instrument suppliers.
Routine Clinical Chemistry Tests
Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Blood Gases, BUN (Blood Urea Nitrogen), Calcium, Cholesterol, Cholinesterase, Creatinine, CK-MB, Electrolytes (Carbon Dioxide/Bicarbonate, Chloride, Potassium, Sodium), Ferritin, Follate/Folic Acid, Fructosamine, GGT, Glucose, HDL, Iron, LDH, Magnesium, Phosphorus, Potassium, Protein, Sodium, Triglycerides, Troponin, Uric Acid, Urinalysis, Vitamin B12.
Endocrine Function Tests
Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, TSH.
Therapeutic Drug Monitoring (TDM) Tests
Amikacin, Carbamazepine, Digoxin, Gentamicin, Lidocaine, Lithium, Methotrexate, Phenobarbital, Phenytoin/Dilatin, NAPA/Procainamide, Quinidine, Theophylline, Tobramycin, Valproic Acid, Vancomycin.
C3, C4, CRP, IgA, IgE Soecific, IgE Total, IgG, Immunoglobulins, Protein Electrophoresis, and others.
Drugs of Abuse
Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine, Propoxyphene, and others.
Emerging technologies and their applications for POC testing.
Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.
Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.
Design criteria for POC testing products.
Alternative business expansion strategies.
Potential market entry barriers and risks.
Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.
The companies analyzed in the report include:
This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and Venture Planning Group's proprietary data files.
Contains 500 pages and 129 tables
SIMILAR MARKET STUDIES
This new 260-page report from VPGMarketResearch.com provides a comprehensive analysis of the Italian drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: ...
July 2015 | $1500 | View Details >>
Truck Scale Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and ...
January 2017 | $2850 | View Details >>
This new report from VPGMarketResearch.com provides analysis of CA 15-3/27-29 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
November 2014 | $0 | View Details >>
The United States Type 2 Diabetes Mellitus Therapeutics Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Type 2 Diabetes Mellitus Therapeutics industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Type ...
November 2015 | $3800 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research